Fierce Pharma Marketing Innovation Week 2025

This talk will explore the use of Data-Triggered promotion to identify HCPs that have discharged their hospitalized invasive candidiasis patients on daily IV therapy vs once -weekly IV therapy and “correct” their prescribing going forward. 

Advances in AI are transforming direct-to-consumer (DTC) audience modeling, enabling more precise and effective engagement while navigating the complex landscape of data privacy. The FDA has long recognized the value of DTC advertising in informing consumer healthcare decisions, but emerging AI capabilities—paired with evolving privacy challenges—require new strategies for responsible audience creation. As AI-driven personalization grows more sophisticated, so do the risks associated with data reconstruction and re-identification. Practitioners and technologists will share how to leverage AI while maintaining trust, ensuring compliance, and adapting to an increasingly complex regulatory environment.

In a world overflowing with metrics, making sense of disparate data from diverse partners and sources is one of pharma marketing's greatest challenges. This panel explores how AI is revolutionizing the way marketers analyze, interpret, and act on data. By leveraging advanced algorithms, marketers can harmonize fragmented metrics, uncover actionable insights, and craft smarter strategies that drive measurable impact.

• Utilize AI to analyze and integrate data from multiple sources, ensuring consistent and accurate insights.
• Transforming raw data into actionable predictions that inform the best path forward and deliver results.
• Aligning data collection and measurement frameworks across partners to streamline reporting and decision-making.

In a digital landscape saturated with information, how can healthcare professionals and organizations cut through the noise and build genuine connections with their audiences? This panel discussion explores the power of authenticity and trust in healthcare social media. Featuring Josh Simon, SVP, Social Center of Excellence, CMI Media Group; Milet Koo, Digital Marketing Leader, Neurocrine; and influencer Dr. Tim, this session will delve into strategies for creating engaging content, fostering meaningful conversations, and navigating the ethical considerations of sharing health information online. Learn how to leverage social media to empower patients, build community, and ultimately improve health outcomes by prioritizing transparency, empathy, and evidence-based information.

Today, AI enables consumerized engagement, ensuring personalized interactions that drive meaningful outcomes. But the future is about dedicated AI agents that don’t just suggest – they act.

In this presentation, we will explore how pharma marketers can leverage AI for seamless engagement that moves beyond personalization to real-time decision-making and high-value execution.

• From Insights to Action: AI’s Role in Personalization – AI-driven personalization has revolutionized how brands engage with consumers and healthcare professionals. We will review the current AI-powered engagement strategies that uncover valuable and actionable insights, optimizing content delivery, message timing, and audience segmentation for maximum impact.
• AI Agents for HVA Execution – Imagine an AI-powered solution that doesn’t just identify a need but executes on it—whether scheduling a rep visit, surfacing critical content, or guiding next-best actions. Discover how pharma marketers can implement AI-driven technology to move beyond engagement, driving measurable impact on prescribing behavior, content consumption, and HCP interactions.
• Measuring Success: The Power of AI-Driven Insights – AI isn’t just about automation—it’s about delivering results. Learn how pharma marketers can leverage real-time data to optimize campaigns, track ROI, and refine strategies that translate AI-driven actions into business growth.

This session explores how organizations can navigate ambiguity and maximize their marketing impact in a rapidly evolving landscape. This session examines agility both internally and externally, highlighting strategies for leveraging in-house teams to deliver cost control and brand consistency while balancing external partnerships for creativity and innovation. Attendees will gain insights into key considerations such as budget, organizational structure, and the trade-offs necessary to achieve alignment and impact in today’s complex marketing environment.

Swoop's VP of Product Romain Bogaerts delves into the transformative power of AI in omnichannel marketing for the pharmaceutical industry. Learning how to connect intelligent audiences to valuable actions will help brand marketers drive brand specific objectives like increasing doctor visits, growing market share, and increasing patient adherence.

This session offers a roadmap for pharma marketers to elevate their omnichannel efforts, ultimately improving patient outcomes while navigating the complex landscape.

As the marketing landscape grows more complex, companies face a pivotal decision: should they build an in-house marketing agency or partner with an external agency? This session explores the strategic considerations, benefits, and trade-offs of both approaches, with insights from industry leaders who have navigated this critical choice.Panelists will provide real-world examples of how they evaluated their options, adapted to changing needs, and achieved marketing excellence—whether by retaining talent internally, leveraging external expertise, or employing a hybrid model.

• Review the case for outsourcing an agency and outline how external agencies bring creative innovation, insights from other industries, and scalability to pharma marketing campaigns.
• Examine how in-house teams can deliver cost control, brand consistency, and a deeper understanding of company goals to maximize impact.
• Evaluate key considerations such as budget, organizational needs, brand structure, and the trade-offs between internal alignment and external creativity.